ZEAL - Zealand Pharma A/S ADR - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $5.53. This is a potential upside of $5.53 (0%) from yesterday's end of day stock price of $0.

Zealand Pharma A/S ADR's activity chart (see below) currently has 10 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 147 days.

Most recent stock forecast was given by DAVID LEBOWITZ from CITI on 31-Mar-2020. First documented stock forecast 12-Sep-2018.

Best performing analysts who are covering ZEAL - Zealand Pharma A/S ADR:

Alan Carr David Lebowitz

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

35

$17.41 (98.98%)

38

3 years 10 months 28 days ago

6/6 (100%)

$0.5 (1.45%)

101

Sell

42

$24.41 (138.77%)

32

4 years 3 months 14 days ago

3/3 (100%)

$10.55 (46.64%)

193

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ZEAL (Zealand Pharma A/S ADR) average time for price targets to be met?

On average it took 147 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on ZEAL (Zealand Pharma A/S ADR) with a proven track record?

ALAN CARR

Which analyst has the current lower performing score on ZEAL (Zealand Pharma A/S ADR) with a proven track record?

DAVID LEBOWITZ

Which analyst has the most public recommendations on ZEAL (Zealand Pharma A/S ADR)?

Alan Carr works at NEEDHAM and has 7 price targets and 7 ratings on ZEAL

Which analyst is the currently most bullish on ZEAL (Zealand Pharma A/S ADR)?

Alan Carr with highest potential upside - $24.41

Which analyst is the currently most reserved on ZEAL (Zealand Pharma A/S ADR)?

David Lebowitz with lowest potential downside - $17.41

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?